NCT00355901终止不适用
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 300
研究概览
简要总结
To assess the effects of visilizumab on the safety of subsequent salvage therapies in subjects who experienced disease progression in a previous visilizumab study and subsequently received salvage therapy.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Previous participation in a visilizumab study of IVSR-UC.
- •Disease progression while enrolled in a previous visilizumab study, and subsequent treatment with salvage therapy.
排除标准
- •Unable to understand the purpose and risks of the study, or unwilling or unable to provide a signed and dated informed consent.
- •For U.S. sites, unwilling or unable to provide authorization to use protected health information.
研究者
相似试验
已完成
1 期
Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative ColitisSevere Ulcerative ColitisNCT00267306Facet Biotech144
招募中
不适用
Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum DisorderNeuromyelitis OpticaNCT06398158University of Texas Southwestern Medical Center35
已完成
不适用
An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in AustraliaMelanomaNCT04146324Bristol-Myers Squibb150
终止
2 期
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationGraft Versus Host DiseaseNCT00720629H. Lee Moffitt Cancer Center and Research Institute8
已完成
不适用
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)Urea Cycle DisordersCrigler Najjar SyndromeNCT02051049Cellaion SA9